Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Paul Horstmeier. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Paul Horstmeier har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:HCAT / Health Catalyst, Inc. | Chief Operating Officer | 204 880 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Paul Horstmeier. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp HCAT / Health Catalyst, Inc. - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i HCAT / Health Catalyst, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel HCAT / Health Catalyst, Inc. - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i HCAT / Health Catalyst, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til min |
Pris ved min |
Maks tap unngått ($) |
Maks tap unngått (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Paul Horstmeier som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-03-24 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 50 000 | 204 880 | 32,28 | 4,42 | 221 000 | 905 570 | |
2023-03-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
F - Taxes | −4 464 | 154 880 | −2,80 | 14,29 | −63 784 | 2 213 018 | |
2022-12-05 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
F - Taxes | −15 561 | 159 344 | −8,90 | 10,65 | −165 720 | 1 696 966 | |
2022-09-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
F - Taxes | −2 869 | 174 905 | −1,61 | 11,60 | −33 295 | 2 029 773 | |
2022-06-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
F - Taxes | −89 | 177 774 | −0,05 | 14,95 | −1 331 | 2 658 112 | |
2022-06-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
F - Taxes | −2 453 | 177 863 | −1,36 | 14,24 | −34 924 | 2 532 253 | |
2022-04-14 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −521 | 18 474 | −2,74 | ||||
2022-04-14 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −520 | 5 728 | −8,32 | ||||
2022-04-14 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −4 167 | 35 402 | −10,53 | ||||
2022-04-14 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −5 208 | 180 316 | −2,81 | 25,16 | −131 045 | 4 537 165 |
2022-04-14 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 521 | 185 524 | 0,28 | 10,80 | 5 627 | 2 003 659 | |
2022-04-14 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 4 167 | 185 003 | 2,30 | 15,84 | 66 005 | 2 930 448 | |
2022-04-14 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 520 | 180 836 | 0,29 | 15,84 | 8 237 | 2 864 442 | |
2022-04-08 |
|
4/A | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −521 | 6 248 | −7,70 | ||||
2022-04-08 |
|
4/A | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −4 166 | 39 569 | −9,53 | ||||
2022-04-08 |
|
4/A | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −201 | 180 316 | −0,11 | 26,02 | −5 229 | 4 690 957 |
2022-04-08 |
|
4/A | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −20 526 | 180 517 | −10,21 | 25,32 | −519 665 | 4 570 221 |
2022-04-08 |
|
4/A | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 4 166 | 201 043 | 2,12 | 15,84 | 65 989 | 3 184 521 | |
2022-04-08 |
|
4/A | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 521 | 196 877 | 0,27 | 15,84 | 8 253 | 3 118 532 | |
2022-03-11 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −521 | 6 248 | −7,70 | ||||
2022-03-11 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −4 166 | 39 569 | −9,53 | ||||
2022-03-11 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −201 | 177 834 | −0,11 | 26,02 | −5 229 | 4 626 387 |
2022-03-11 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −23 008 | 178 035 | −11,44 | 25,30 | −582 056 | 4 503 929 |
2022-03-11 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 4 166 | 201 043 | 2,12 | 15,84 | 65 989 | 3 184 521 | |
2022-03-11 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 521 | 196 877 | 0,27 | 15,84 | 8 253 | 3 118 532 | |
2022-03-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
F - Taxes | −491 | 196 356 | −0,25 | 26,69 | −13 105 | 5 240 997 | |
2022-03-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
A - Award | 3 164 | 196 847 | 1,63 | ||||
2022-03-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
F - Taxes | −3 015 | 193 683 | −1,53 | 26,63 | −80 292 | 5 157 914 | |
2022-02-28 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
A - Award | 100 000 | 196 698 | 103,41 | ||||
2022-02-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −6 584 | 21 527 | −23,42 | ||||
2022-02-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −4 166 | 43 735 | −8,70 | ||||
2022-02-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −3 477 | 96 698 | −3,47 | 29,38 | −102 154 | 2 840 987 |
2022-02-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −7 273 | 100 175 | −6,77 | 28,97 | −210 692 | 2 901 970 |
2022-02-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 6 584 | 107 448 | 6,53 | 10,30 | 67 815 | 1 106 714 | |
2022-02-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 4 166 | 100 864 | 4,31 | 15,84 | 65 989 | 1 597 686 | |
2022-01-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −4 127 | 47 901 | −7,93 | ||||
2022-01-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −6 623 | 6 769 | −49,45 | ||||
2022-01-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −1 496 | 96 698 | −1,52 | 38,04 | −56 903 | 3 678 092 |
2022-01-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −4 999 | 98 194 | −4,84 | 37,15 | −185 736 | 3 648 369 |
2022-01-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −4 255 | 103 193 | −3,96 | 35,89 | −152 707 | 3 703 473 |
2022-01-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 6 623 | 107 448 | 6,57 | 15,84 | 104 908 | 1 701 976 | |
2022-01-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 4 127 | 100 825 | 4,27 | 15,84 | 65 372 | 1 597 068 | |
2021-12-29 |
|
4/A | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −6 063 | 52 028 | −10,44 | ||||
2021-12-29 |
|
4/A | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −2 789 | 99 180 | −2,74 | 39,89 | −111 250 | 3 956 171 |
2021-12-29 |
|
4/A | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −2 674 | 101 969 | −2,56 | 38,76 | −103 644 | 3 952 318 |
2021-12-29 |
|
4/A | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −600 | 104 643 | −0,57 | 37,97 | −22 780 | 3 972 949 |
2021-12-29 |
|
4/A | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 6 063 | 105 243 | 6,11 | 15,84 | 96 038 | 1 667 049 | |
2021-12-29 |
|
4/A | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −400 | 96 698 | −0,41 | 40,61 | −16 244 | 3 926 906 |
2021-12-29 |
|
4/A | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −2 082 | 97 098 | −2,10 | 39,97 | −83 215 | 3 880 891 |
2021-12-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −400 | 90 635 | −0,44 | 40,61 | −16 244 | 3 680 687 |
2021-12-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −2 082 | 91 035 | −2,24 | 39,97 | −83 215 | 3 638 560 |
2021-12-07 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −2 789 | 93 117 | −2,91 | 39,89 | −111 250 | 3 714 325 |
2021-12-07 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −2 674 | 95 906 | −2,71 | 38,76 | −103 644 | 3 717 317 |
2021-12-07 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −600 | 98 580 | −0,60 | 37,97 | −22 780 | 3 742 757 |
2021-12-07 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
F - Taxes | −9 261 | 99 180 | −8,54 | 41,95 | −388 476 | 4 160 353 | |
2021-11-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −10 750 | 47 341 | −18,51 | ||||
2021-11-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −622 | 108 441 | −0,57 | 53,58 | −33 325 | 5 809 998 |
2021-11-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −2 001 | 109 063 | −1,80 | 52,68 | −105 410 | 5 745 275 |
2021-11-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −8 127 | 111 064 | −6,82 | 51,67 | −419 915 | 5 738 577 |
2021-11-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 10 750 | 119 191 | 9,91 | 15,84 | 170 280 | 1 887 985 | |
2021-10-07 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −10 750 | 58 091 | −15,62 | ||||
2021-10-07 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −1 000 | 108 441 | −0,91 | 48,78 | −48 783 | 5 290 077 |
2021-10-07 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −9 750 | 109 441 | −8,18 | 48,02 | −468 169 | 5 255 061 |
2021-10-07 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 10 750 | 119 191 | 9,91 | 15,84 | 170 280 | 1 887 985 | |
2021-09-08 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −6 063 | 68 841 | −8,09 | ||||
2021-09-08 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −2 535 | 108 441 | −2,28 | 54,91 | −139 189 | 5 954 170 |
2021-09-08 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −6 063 | 110 976 | −5,18 | 54,89 | −332 817 | 6 091 817 |
2021-09-08 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 6 063 | 117 039 | 5,46 | 15,84 | 96 038 | 1 853 898 | |
2021-09-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
F - Taxes | −2 153 | 110 976 | −1,90 | 54,23 | −116 762 | 6 018 462 | |
2021-08-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −10 750 | 74 904 | −12,55 | ||||
2021-08-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −2 055 | 113 129 | −1,78 | 56,93 | −116 994 | 6 440 570 |
2021-08-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −3 153 | 115 184 | −2,66 | 56,20 | −177 185 | 6 472 846 |
2021-08-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −5 542 | 118 337 | −4,47 | 55,16 | −305 708 | 6 527 706 |
2021-08-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 10 750 | 123 879 | 9,50 | 15,84 | 170 280 | 1 962 243 | |
2021-07-08 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −10 750 | 85 654 | −11,15 | ||||
2021-07-08 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −6 692 | 113 129 | −5,58 | 57,19 | −382 748 | 6 470 402 |
2021-07-08 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −4 058 | 119 821 | −3,28 | 56,69 | −230 056 | 6 792 880 |
2021-07-08 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 10 750 | 123 879 | 9,50 | 15,84 | 170 280 | 1 962 243 | |
2021-06-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −6 063 | 96 404 | −5,92 | ||||
2021-06-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −1 827 | 113 129 | −1,59 | 55,90 | −102 127 | 6 323 753 |
2021-06-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −200 | 114 956 | −0,17 | 54,76 | −10 951 | 6 294 416 |
2021-06-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −545 | 115 156 | −0,47 | 53,73 | −29 284 | 6 187 666 |
2021-06-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −45 | 115 701 | −0,04 | 56,37 | −2 537 | 6 521 730 |
2021-06-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −4 516 | 115 746 | −3,76 | 55,87 | −252 305 | 6 466 625 |
2021-06-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −300 | 120 262 | −0,25 | 54,65 | −16 395 | 6 572 318 |
2021-06-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −1 202 | 120 562 | −0,99 | 53,77 | −64 634 | 6 482 908 |
2021-06-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 6 063 | 121 764 | 5,24 | 15,84 | 96 038 | 1 928 742 | |
2021-06-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
F - Taxes | −2 115 | 115 701 | −1,80 | 53,88 | −113 947 | 6 233 472 | |
2021-05-07 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −8 750 | 102 467 | −7,87 | ||||
2021-05-07 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −300 | 117 816 | −0,25 | 55,92 | −16 775 | 6 587 882 |
2021-05-07 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −786 | 118 116 | −0,66 | 54,71 | −43 001 | 6 462 020 |
2021-05-07 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −1 830 | 118 902 | −1,52 | 55,89 | −102 274 | 6 645 100 |
2021-05-07 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −6 920 | 120 732 | −5,42 | 54,67 | −378 325 | 6 600 575 |
2021-05-07 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 8 750 | 127 652 | 7,36 | 15,84 | 138 600 | 2 022 008 | |
2021-04-08 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −5 800 | 118 902 | −4,65 | 48,09 | −278 926 | 5 718 080 |
2021-03-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −1 712 | 124 702 | −1,35 | 46,27 | −79 210 | 5 769 675 |
2021-03-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −3 147 | 126 414 | −2,43 | 45,73 | −143 903 | 5 780 520 |
2021-03-09 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −1 712 | 129 561 | −1,30 | 44,47 | −76 132 | 5 761 565 |
2021-03-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
F - Taxes | −43 | 131 273 | −0,03 | 49,63 | −2 134 | 6 514 816 | |
2021-03-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
F - Taxes | −1 374 | 131 316 | −1,04 | 48,60 | −66 772 | 6 381 537 | |
2021-02-22 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
A - Award | 60 000 | 132 690 | 82,54 | ||||
2021-02-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −10 750 | 124 750 | −7,93 | ||||
2021-02-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −1 740 | 72 690 | −2,34 | 49,91 | −86 840 | 3 627 820 |
2021-02-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −9 010 | 74 430 | −10,80 | 49,35 | −444 644 | 3 673 128 |
2021-02-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 10 750 | 83 440 | 14,79 | 15,84 | 170 280 | 1 321 690 | |
2021-01-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −10 750 | 135 500 | −7,35 | ||||
2021-01-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −3 698 | 72 690 | −4,84 | 43,47 | −160 751 | 3 159 812 |
2021-01-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −7 052 | 76 388 | −8,45 | 42,57 | −300 197 | 3 251 761 |
2021-01-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 10 750 | 83 440 | 14,79 | 15,84 | 170 280 | 1 321 690 | |
2020-12-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −2 368 | 72 690 | −3,15 | 35,96 | −85 157 | 2 614 041 |
2020-12-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −6 196 | 75 058 | −7,63 | 35,01 | −216 920 | 2 627 758 |
2020-12-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −10 750 | 146 250 | −6,85 | ||||
2020-12-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −100 | 81 254 | −0,12 | 35,85 | −3 585 | 2 912 956 |
2020-12-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −10 650 | 81 354 | −11,58 | 34,99 | −372 691 | 2 846 943 |
2020-12-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 10 750 | 92 004 | 13,23 | 15,84 | 170 280 | 1 457 343 | |
2020-11-04 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −10 750 | 157 000 | −6,41 | ||||
2020-11-04 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −1 001 | 81 254 | −1,22 | 34,30 | −34 334 | 2 787 012 |
2020-11-04 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −9 749 | 82 255 | −10,60 | 33,63 | −327 859 | 2 766 236 |
2020-11-04 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 10 750 | 92 004 | 13,23 | 15,84 | 170 280 | 1 457 343 | |
2020-10-02 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −10 750 | 167 750 | −6,02 | ||||
2020-10-02 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −2 015 | 81 254 | −2,42 | 36,89 | −74 333 | 2 997 460 |
2020-10-02 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −8 735 | 83 269 | −9,49 | 36,31 | −317 150 | 3 023 323 |
2020-10-02 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 10 750 | 92 004 | 13,23 | 15,84 | 170 280 | 1 457 343 | |
2020-09-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −10 750 | 2 642 | −80,27 | ||||
2020-09-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −5 472 | 81 254 | −6,31 | 32,04 | −175 323 | 2 603 378 |
2020-09-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −5 278 | 86 726 | −5,74 | 31,25 | −164 938 | 2 710 188 |
2020-09-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 10 750 | 92 004 | 13,23 | 15,84 | 170 280 | 1 457 343 | |
2020-08-05 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −10 750 | 13 392 | −44,53 | ||||
2020-08-05 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −1 994 | 81 254 | −2,40 | 35,02 | −69 830 | 2 845 515 |
2020-08-05 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −8 806 | 83 248 | −9,57 | 35,62 | −313 670 | 2 965 294 |
2020-08-05 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 10 750 | 92 054 | 13,22 | 15,84 | 170 280 | 1 458 135 | |
2020-07-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −3 888 | 0 | −100,00 | ||||
2020-07-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −6 004 | 0 | −100,00 | ||||
2020-07-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −858 | 24 142 | −3,43 | ||||
2020-07-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −300 | 75 000 | −0,40 | 29,77 | −8 931 | 2 232 750 |
2020-07-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −500 | 75 300 | −0,66 | 29,79 | −14 895 | 2 243 187 |
2020-07-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −5 504 | 75 800 | −6,77 | 28,85 | −158 790 | 2 186 830 |
2020-07-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −3 588 | 81 304 | −4,23 | 28,83 | −103 442 | 2 343 994 |
2020-07-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −858 | 84 892 | −1,00 | 29,11 | −24 976 | 2 471 206 |
2020-07-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 3 888 | 85 750 | 4,75 | 10,30 | 40 046 | 883 225 | |
2020-07-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 858 | 81 862 | 1,06 | 15,84 | 13 591 | 1 296 694 | |
2020-07-06 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 6 004 | 81 004 | 8,01 | 10,80 | 64 843 | 874 843 | |
2020-06-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −5 250 | 0 | −100,00 | ||||
2020-06-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −5 500 | 3 888 | −58,59 | ||||
2020-06-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −5 250 | 75 000 | −6,54 | 26,97 | −141 592 | 2 022 750 |
2020-06-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −5 500 | 80 250 | −6,41 | 26,97 | −148 335 | 2 164 342 |
2020-06-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 5 250 | 85 750 | 6,52 | 6,24 | 32 760 | 535 080 | |
2020-06-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 5 500 | 80 500 | 7,33 | 10,30 | 56 650 | 829 150 | |
2020-05-05 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −10 750 | 5 250 | −67,19 | ||||
2020-05-05 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −3 338 | 75 000 | −4,26 | 26,10 | −87 122 | 1 957 500 |
2020-05-05 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −7 412 | 78 338 | −8,64 | 25,07 | −185 819 | 1 963 934 |
2020-05-05 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 10 750 | 85 750 | 14,33 | 6,24 | 67 080 | 535 080 | |
2020-04-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −10 750 | 16 000 | −40,19 | ||||
2020-04-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −4 734 | 75 000 | −5,94 | 27,20 | −128 765 | 2 040 000 |
2020-04-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −5 416 | 79 734 | −6,36 | 26,32 | −142 549 | 2 098 599 |
2020-04-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −600 | 85 150 | −0,70 | 25,20 | −15 120 | 2 145 780 |
2020-04-03 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 10 750 | 85 750 | 14,33 | 6,24 | 67 080 | 535 080 | |
2020-03-05 |
|
4 | HCAT |
Health Catalyst, Inc.
Stock Option (Right to Buy) |
M - Exercise | −10 750 | 26 750 | −28,67 | ||||
2020-03-05 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −2 228 | 75 000 | −2,88 | 29,24 | −65 147 | 2 193 000 |
2020-03-05 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
S - Sale | X | −8 522 | 77 228 | −9,94 | 28,34 | −241 513 | 2 188 642 |
2020-03-05 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
M - Exercise | 10 750 | 85 750 | 14,33 | 6,24 | 67 080 | 535 080 | |
2020-01-02 |
|
4 | HCAT |
Health Catalyst, Inc.
Common Stock |
A - Award | 75 000 | 75 000 |